About Insufflation Needles
The rising number of laparoscopy surgeries and increasing the prevalence of chronic diseases will help to boost the global surgical needle market in the forecasted period. An insufflation needle is a medical device used to blow something (such as a gas, powder, or vapor) into a body cavity after an injury or surgery. Rising healthcare expenditure, an increasing number of surgeries and burns and the rising number of hospitals are driving the market.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
Crucial players are involved in espousing strategies similar as combinations & accessions, hookups, and the launch of new technologically advanced products and services to strengthen their base in the request. crucial players are significantly investing in exploration and development to manufacture technologically advanced products. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Insufflation Needles market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Johnson & Johnson (United States), GENICON (United States), Maxer Endoscopy GmbH (Germany), Unimax Medical Systems Inc. (Taiwan), Medtronic plc (Ireland), Teleflex, Inc. (United States), WISAP Medical Technology GmbH (Germany), Grena Ltd (United Kingdom) and LaproSurge Ltd ( United Kingdom) are some of the key players that are part of study coverage.
Segmentation Overview
AMA Research has segmented the market of Global Insufflation Needles market by , Application (Hospital, Clinic, Surgery Centers & Tissue Banks and Others) and Region.
On the basis of geography, the market of Insufflation Needles has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Material , the sub-segment i.e. Plastic will boost the Insufflation Needles market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Length, the sub-segment i.e. 120 mm will boost the Insufflation Needles market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
High Usage in Abdominal Endoscopy
Market Growth Drivers:
Growing Demand for Minimally Invasive Therapies and High Prevalence of Chronic Diseases
Challenges:
Safety and Sterilization Concerns on Developing Surgical Needles
Restraints:
Rising Needlestick Injuries and Infections
Opportunities:
Expanding Injectables Market, Rising Use of Safety Needles and Escalating Healthcare Infrastructure across the Emerging Economies
Market Leaders and their expansionary development strategies
In 2021, Medtronic plc the global leader in medical technology, announced that it has entered into a definitive agreement with Intersect ENT a global ear, nose, and throat (ENT) medical technology leader dedicated to transforming patient care, in which Medtronic will acquire all outstanding shares of Intersect ENT for USD 28.25 per share in an all-cash transaction implying an enterprise value of approximately USD 1.1 billion.
In Dec 2019, Johnson & Johnson announced an agreement to acquire the remaining stake in Verb Surgical Inc. following a successful strategic collaboration with Verily, an Alphabet company. Verb Surgical’s world-class robotics and data science capabilities combined with Johnson & Johnson’s health care leadership and global reach advance the company’s vision to make medical interventions smarter, less invasive and more personalized.
Key Target Audience
Insufflation Needle manufacturers, Suppliers and Distributors, Injectable device manufacturers, Clinical centers and Pharmaceuticals Companies
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.